Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... [Yahoo! Finance]
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Yahoo! Finance
Full Year Revenue Guidance: Between $1.87 billion and $1.88 billion. Adjusted EBITDA: $39 million, 23% growth year over year. Specialty Performance Suite Care Margin: Approximately 7%. Cash and Equivalents: $116.7 million at the end of the quarter. Net Debt: $910 million, with a net leverage ratio of approximately 5.5 times expected by year-end. 2026 Revenue Under Contract: Approximately $2.5 billion. New Contracts for 2026: Expected to add more than $550 million in new revenue. Capital Allocation: Plan to pay down approximately $100 million of senior term loan. Warning! GuruFocus has detected 4 Warning Signs with EVH. Is EVH fairly valued? Test your thesis with our free DCF calculator. Release Date: November 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Evolent Health Inc ( NYSE:EVH ) reported Q3 revenue of $479.5 million, which was at the top of their guidance range. The compa
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.MarketBeat
- Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.MarketBeat
- Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]Yahoo! Finance
- Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.MarketBeat
EVH
Earnings
- 11/6/25 - Beat
EVH
Sec Filings
- 12/2/25 - Form 8-K
- 11/19/25 - Form 4
- 11/14/25 - Form SCHEDULE
- EVH's page on the SEC website